Literature DB >> 2248291

Arthrogryposis, cholestatic pigmentary liver disease and renal dysfunction: report of a second family.

M Di Rocco1, E Reboa, A Barabino, A Larnaout, M Canepa, C Savioli, M Cremonte, C Borrone.   

Abstract

We report on a boy, born to consanguineous parents, who had arthrogryposis, cholestatic liver disease, and renal dysfunction. The child died at age 2 months, and autopsy showed pigmentary storage disease in liver cells, nephrocalcinosis, and rarefaction of motor neuron cells in the anterior horns of spinal cord. This association, reported in 1979 by Nezelof et al., is a distinctive syndrome. The possibility of an autosomal recessive or an X-linked inheritance is discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2248291     DOI: 10.1002/ajmg.1320370214

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  5 in total

1.  Arthrogryposis multiplex congenita, renal dysfunction, and cholestasis syndrome.

Authors:  J M Saraiva; H C Mota
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

Review 2.  Liver histology in the arthrogryposis multiplex congenita, renal dysfunction, and cholestasis (ARC) syndrome: report of three new cases and review.

Authors:  S P Horslen; O W Quarrell; M S Tanner
Journal:  J Med Genet       Date:  1994-01       Impact factor: 6.318

Review 3.  Genetics of familial intrahepatic cholestasis syndromes.

Authors:  S W C van Mil; R H J Houwen; L W J Klomp
Journal:  J Med Genet       Date:  2005-06       Impact factor: 6.318

Review 4.  Arthrogryposis, renal dysfunction and cholestasis syndrome: report of five patients from three Italian families.

Authors:  M Di Rocco; F Callea; B Pollice; M Faraci; F Campiani; C Borrone
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

Review 5.  Arc syndrome without arthrogryposis, with hip dislocation and renal glomerulocystic appearance: a case report.

Authors:  Ebru Arhan; Arzu Meltem Yusufoğlu; Tülin Revide Sayli
Journal:  Eur J Pediatr       Date:  2008-10-30       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.